1 Yamada M, Moriguch Y , Mitani T, Aoyama T, Arai H. Age-dependent changes in skeletal muscle mass and visceral fat area in Japanese adults from 40 to 79 years-of-age [J].Geriatr Gerontol Int 2014, 14 (Suppl. 1): 8-14. DOI: 10.1111/ggi.12209.
2 Psutka SP, Carrasco A, Schmit GD, Moynagh MR, Boorjian SA, Frank I, et al. Sarcopenia in patients with bladder cancer undergoing radical cystectomy: impact on cancer-specific and all-cause mortality[J]. Cancer. 2014, 120(18):2910-8. DOI: 10.1002/cncr.28798.
3 Biolo G, Cederholm T, Muscaritoli M. Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia[J]. Clin Nutr. 2014, 33(5):737-48. DOI: 10.1016/j.clnu.2014.03.007.
4 Bhanji RA, Carey EJ, Yang L, Watt KD. The Long Winding Road to Transplant: How Sarcopenia and Debility Impact Morbidity and Mortality on the Waitlist[J]. Clin Gastroenterol Hepatol 2017, 15(10): 1492–1497. DOI: 10.1016/j.cgh.2017.04.004.
5 Meyer MM , Levin K, Grimmsmann T, Beck-Nielsen H, Klein HH. Insulin Signalling in Skeletal Muscle of Subjects With or Without Type II-diabetes and First Degree Relatives of Patients With the Disease[J]. Diabetologia, 2002, 45 (6): 813-22. DOI: 10.1007/s00125-002-0830-9.
6 Kim TN, Park MS, Lim KI, Choi HY, Yang SJ, Yoo HJ, et al. Relationships between sarcopenic obesity and insulin resistance, inflammation, and vitamin D status: the Korean Sarcopenic Obesity Study[J]. Clin Endocrinol (Oxf), 2013, 78(4), 525-532. DOI: 10.1111/j.1365-2265.2012.04433.x.
7 Kim KS, Park KS, Kim MJ, Kim SK, Cho YW, Park SW. Type 2 Diabetes Is Associated With Low Muscle Mass in Older Adults[J]. Geriatr Gerontol Int,2014,14 Suppl 1:115-21. DOI: 10.1111/ggi.12189.
8 Kim TN, Park MS, Yang SJ, Yoo HJ, Kang HJ, Song W, et al. Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes[J]. Diabetes Care. 2010;33(7):1497. DOI: 10.2337/dc09-2310.
9 Son JW, Lee SS, Kim SR, Yoo SJ, Cha BY, Son HY, et al. Low muscle mass and risk of type 2 diabetes in middle-aged and older adults: findings from the KoGES[J]. Diabetologia. 2017;60(5):865–872. DOI: 10.1007/s00125-016-4196-9.
10 Larsen BA, Wassel CL, Kritchevsky SB, Strotmeyer ES, Criqui MH, Kanaya AM, et al. Association of Muscle Mass, Area, and Strength With Incident Diabetes in Older Adults: The Health ABC Study[J]. J Clin Endocrinol Metab. 2016, 101(4): 1847-1855. DOI: 10.1210/jc.2015-3643.
11 Dai W, Ye Y, Liu AZ, Wen SW, Deng J, Wu X, et al. Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus: A Meta-Analysis[J]. Medicine (Baltimore),2017, 96 (39), e8179. DOI: 10.1097/MD.0000000000008179.
12 National Workshop on Fatty Liver and Alcoholic Liver Disease, Chinese Society of Hepatology, Chinese Medical Association Fatty Liver Expert Committee, Chinese Medical Doctor Association. Guideline of prevention and treatment for nonalcoholic fatty liver disease: a 2018 update [J]. J Mod Med Health, 2018, 34(5) :641-649.
13 Park SK, Seo MH, Shin HC, Ryoo JH. The clinical availability of non-alcoholic fatty liver disease as an early predictor of type 2 diabetes mellitus in korean men: 5-years’ prospective cohort study [J]. Hepatology. 2012; 57: 1378–1383. DOI: 10.1002/hep.26183.
14 Hong HC, Hwang SY, Choi HY, Yoo HJ, Seo JA, Kim SG, et al. Relationship between Sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic Obesity Study. Hepatology. 2014, 59(5):1772‐1778. DOI: 10.1002/hep.26716.
15 Koo BK, Kim D, Joo SK, Kim JH, Chang MS, Kim BG, et al. Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis [J]. Hepatology, 2017, 66:123‑31. DOI: 10.1016/j.jhep.2016.08.019.
16 Kim G, Lee SE, Lee YB, Jun JE, Ahn J, Bae JC, et al. Relationship Between Relative Skeletal Muscle Mass and Nonalcoholic Fatty Liver Disease: A 7-Year Longitudinal Study[J]. Hepatology, 2018, 68(5): 1755-1768. DOI: 10.1002/hep.30049.
17 Gao X, Hofman A, Hu YU, Lin HD, Zhu CW, Jeekel J, et al. The Shanghai Changfeng Study: a community-based prospective cohort study of chronic diseases among middle-aged and elderly: objectives and design[J]. Eur J Epidemiol. 2010, 25:885-893. DOI: 10.1007/s10654-010-9525-6.
18 Lin HD, Li Q, Hu Y, Zhu CW, Ma H, Gao J, et al. The prevalence of multiple noncommunicable diseases among middle-aged and elderly people: the Shanghai Changfeng Study[J]. Eur J Epidemiol. 2017,32(2):159-163. DOI: 10.1007/s10654-016-0219-6.
19 Xia MF, Yan HM, He WY, Li XM, Li CL, Yao XZ, et al. Standardized ultrasound hepatic/renal ratio and hepatic attenuation rate to quantify liver fat content:an improvement method[J]. Obesity. 2012, 20: 444-452. DOI: 10.1038/oby.2011.302.
20 Kim YS, Lee Y, Chung YS, Lee DJ, Joo NS, Hong D, et al. Prevalence of sarcopenia and sarcopenic obesity in the Korean population based on the Fourth Korean National Health and Nutritional Examination Surveys[J]. J Gerontol A Biol Sci Med Sci 2012, 67: 1107-1113. DOI: 10.1093/gerona/gls071.
21 Chen CM, Kong LZ. Chinese Guidelines for the prevention and Control of overweight and obesity in adults [M]. Beijing: People's Medical Publishing House, 2006.
22 ORGANIZATION WHO. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus. [M]. Department of Noncommunicable Disease Surveillance Geneva. Geneva: WHO 1999.
23 Srikanthan P, Karlamangla AS. Relative muscle mass is inversely associated with insulin resistance and prediabetes. Findings from the third National Health and Nutrition Examination Survey[J]. J Clin Endocrinol Metab. 2011; 96:2898-2903. DOI: 10.1210/jc.2011-0435.
24 Hong S, Chang Y, Jung HS, Yun KE, Shin H, Ryu S.. Relative muscle mass and the risk of incident type 2 diabetes: A cohort study[J]. PLoS One. 2017, 12(11): e0188650. DOI: 10.1371/journal.pone.0188650.
25 Son JW, Lee SS, Kim SR, Yoo SJ, Cha BY, Son HY, et al. Low muscle mass and risk of type 2 diabetes in middle-aged and older adults: findings from the KoGES. Diabetologia, 2017, 60:865-872. DOI: 10.1007/s00125-016-4196-9.
26 Lu T, Wang Y, Ting Dou T, Xue B, Tan Y, Yang J.. Pancreatic Fat Content Is Associated With β-Cell Function and Insulin Resistance in Chinese Type 2 Diabetes Subjects[J].Endocr J, 2019,66 (3), 265-270. DOI: 10.1507/endocrj.EJ18-0436.
27 Beaudry KM, Devries MC. Sex-based Differences in Hepatic and Skeletal Muscle Triglyceride Storage and Metabolism 1[J]. Appl Physiol Nutr Metab, 2019, 44 (8): 805-813. DOI: 10.1139/apnm-2018-0635.
28 Lundsgaard AM, Kiens B. Gender Differences in Skeletal Muscle Substrate Metabolism-Molecular Mechanisms and Insulin Sensitivity[J]. Front Endocrinol (Lausanne), 2014, 5:195. DOI: 10.3389/fendo.2014.00195.
29 Palmisano BT, Zhu L, Eckel RH, Stafford JM. Sex differences in lipid and lipoprotein metabolism[J]. Mol Metab. 2018;15:45-55. DOI: 10.1016/j.molmet.2018.05.008.
30 Muka T, Nano J, Jaspers L, Meun C, Bramer WM, Hofman A,et al. Associations of Steroid Sex Hormones and Sex Hormone-Binding Globulin With the Risk of Type 2 Diabetes in Women: A Population-Based Cohort Study and Meta-analysis[J]. Diabetes 2017, 66(3):577-586. DOI: 10.2337/db16-0473.
31 Tilg H, Moschen AR, Roden M. NAFLD and Diabetes Mellitus [J]. Nat Rev Gastroenterol Hepatol, 2017, 14 (1), 32-42. DOI: 10.1038/nrgastro.2016.147.
32 Mesinovic J, Zengin A, Courten BD, Ebeling PR, Scott D. Sarcopenia and type 2 diabetes mellitus:a bidirectional relationship [J]. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019,12:1057-1072. DOI: 10.2147/DMSO.S186600.
33 Thiebaud D, Jacot E, DeFronzo RA, Maeder E, Jequier E, Felber JP. The effect of graded doses of insulin on total glucose uptake, glucose oxidation, and glucose storage in man[J]. Diabetes, 1982, 31(11) :957–963. DOI: 10.2337/diacare.31.11.957.
34 Ferrannini E, Iozzo P, Virtanen KA, Honka MJ, Bucci M, Nuutila P. Adipose Tissue and Skeletal Muscle Insulin-Mediated Glucose Uptake in Insulin Resistance: Role of Blood Flow and Diabetes[J]. Am J Clin Nutr, 2018, 108 (4), 749-758. DOI: 10.1093/ajcn/nqy162.
35 Cleasby ME, Jamieson PM, Atherton PJ. Insulin resistance and sarcopenia: mechanistic links between common co-morbidities[J]. J Endocrinol, 2016, 229 (2), R67-81. DOI: 10.1530/JOE-15-0533.
36 Li XH, Li ZM, Zhao MH, Nie YX, Liu PS, Zhu YL, et al. Skeletal Muscle Lipid Droplets and the Athlete's Paradox [J]. Cells 2019, 8 (3). DOI: 10.3390/cells8030249.
37 Pedersen BK, Febbraio MA. Muscles, Exercise and Obesity: Skeletal Muscle as a Secretory Organ[J]. Nat Rev Endocrinol, 2012, 8 (8):457-65. DOI: 10.1038/nrendo.2012.49.
38 Perakakis N, Triantafyllou GA, Fernández-Real JM, Huh JY, Park KH, Seufert J, et al. Physiology and Role of Irisin in Glucose Homeostasis [J]. Nat Rev Endocrinol, 2017,13(6):324-337. DOI: 10.1038/nrendo.2016.221.
39 Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis[J]. Age and Ageing, 2010,39:412-423.DOI: 10.1093/ageing/afq034.